Home
Search

Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
John F. Crowley, President and CEO of the…
“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the United States and the cornerstone of America’s…
Learn more
CSBA Letter to Congressional Leadership on Most…
Learn more
CSBA Letter to Congressional Leadership on…
The Council of State Bioscience Associations (CSBA) is a coalition of independent state and territory-based non-profit trade associations, each of which advocates for public policies that support responsible development and delivery of innovative…
Learn more
All Letters, Testimony & Comments
  • Show All
Search
Results
BIO Submits Testimony to House Science Subcommittee Hearing on Sustainable Aviation Fuels
March 24, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Science and Technology and Space and Aeronautics Subcommittee hearing entitled, "Examining R&D…
BIO Letter to New Mexico Governor on Clean Fuel Standard in Special Session
March 22, 2021
I write today on behalf of the Biotechnology Industry Organization (BIO) – the world’s largest biotechnology trade group – to urge you to put Senate Bill 11 – the New Mexico Clean Fuel Standard Act – on the agenda for the March 31 special session of…
BIO Testimony to House Energy and Commerce Subcommittee Hearing on the CLEAN Future Act
March 18, 2021
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States House of Representatives Committee on Energy and Commerce Subcommittee on Environment and Climate Change hearing entitled, "The…
BIO Letter to DEFRA Consultation on the Regulation of Genetic Technologies
March 17, 2021
The Biotechnology Innovation Organization (BIO) welcomes the United Kingdom’s (UK) consultation on the application of genome editing in the breeding of plants and animals.  The UK has the unique opportunity to be the first country within Europe…
BIO Submits Testimony to Senate Agriculture Committee's First Climate Hearing in 2021
March 11, 2021
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States Senate Committee on Agriculture, Nutrition, and Forestry hearing entitled, “Farmers and Foresters: Opportunities to Lead in Tackling…
BIO Statement to House Ag Hearing on Food Insecurity
March 11, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture hearing entitled, "A Look at Food Insecurity in America." The Committee's hearing…
BIO Sends Letter to President Biden Discussing Collaboration to Ensure Patient Access to COVID Treatments
March 8, 2021
BIO President and CEO Dr. Michelle McMurry-Heath sent President Biden a letter sharing thoughts on how to best work together with global partners to ensure that patients around the world get access to COVID vaccines, therapeutics, and…
BIO Supports Emergency Relief for Black Farmers as Part of COVID Relief
March 3, 2021
The Biotechnology Innovation Organization (BIO) applauds the introduction of the Emergency Relief for Farmers of Color Act and welcomes the inclusion of provisions from this legislation in the American Rescue Plan.  BIO is committed to…
BIO Comments on USDA Rulemaking on Animal Biotechnology
February 26, 2021
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Department of Agriculture’s (USDA’s) advance notice of proposed rulemaking and request for public comment on a proposed framework for oversight of certain…
BIO, as part of a coalition of other trade associations, wrote a letter to House leadership in support of H.R. 5, the Equality Act.
February 26, 2021
Equality of opportunity is a key pillar of our great democracy—one that allows all people to pursue their American Dream—and part of what makes our nation exceptional. Our industries, representing and employing tens of millions of Americans,…